These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37519166)

  • 21. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
    Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
    Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
    Olsson B; Portelius E; Cullen NC; Sandelius Å; Zetterberg H; Andreasson U; Höglund K; Irwin DJ; Grossman M; Weintraub D; Chen-Plotkin A; Wolk D; McCluskey L; Elman L; Shaw LM; Toledo JB; McBride J; Hernandez-Con P; Lee VM; Trojanowski JQ; Blennow K
    JAMA Neurol; 2019 Mar; 76(3):318-325. PubMed ID: 30508027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults.
    He L; Morley JE; Aggarwal G; Nguyen AD; Vellas B; de Souto Barreto P;
    Sci Rep; 2021 Jun; 11(1):13394. PubMed ID: 34183688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A meta-analysis on CSF neurogranin levels for the diagnosis of Alzheimer's disease and mild cognitive impairment.
    Mavroudis IA; Petridis F; Chatzikonstantinou S; Kazis D
    Aging Clin Exp Res; 2020 Sep; 32(9):1639-1646. PubMed ID: 31463927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease.
    Lin YS; Lee WJ; Wang SJ; Fuh JL
    Sci Rep; 2018 Nov; 8(1):17368. PubMed ID: 30478269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum neurofilament light chain level as a predictor of cognitive stage transition.
    Lee EH; Kwon HS; Koh SH; Choi SH; Jin JH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J
    Alzheimers Res Ther; 2022 Jan; 14(1):6. PubMed ID: 34996525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease.
    Yao W; Zhang X; Zhao H; Xu Y; Bai F;
    J Alzheimers Dis; 2022; 89(2):505-518. PubMed ID: 35871350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Potential of Neurofilament Light as a Biomarker in Alzheimer's Disease.
    Xiong YL; Meng T; Luo J; Zhang H
    Eur Neurol; 2021; 84(1):6-15. PubMed ID: 33477142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain.
    Chen CY; Chiu CC; Huang CY; Cheng YC; Huang MC; Kuo PH; Chen WY
    BMC Geriatr; 2024 Apr; 24(1):344. PubMed ID: 38627748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide association study identifies two loci influencing plasma neurofilament light levels.
    Li JQ; Yuan XZ; Li HY; Cao XP; Yu JT; Tan L; Chen WA;
    BMC Med Genomics; 2018 May; 11(1):47. PubMed ID: 29747637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated plasma neurofilament light predicts a faster rate of cognitive decline over 5 years in participants with objectively-defined subtle cognitive decline and MCI.
    Bangen KJ; Thomas KR; Weigand AJ; Edmonds EC; Clark AL; Solders S; Delano-Wood L; Galasko DR; Bondi MW;
    Alzheimers Dement; 2021 Oct; 17(10):1756-1762. PubMed ID: 33860596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma apolipoprotein E levels in longitudinally followed patients with mild cognitive impairment and Alzheimer's disease.
    Giannisis A; Al-Grety A; Carlsson H; Patra K; Twohig D; Sando SB; Lauridsen C; Berge G; Grøntvedt GR; Bråthen G; White LR; Kultima K; Nielsen HM
    Alzheimers Res Ther; 2022 Aug; 14(1):115. PubMed ID: 36002891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
    Giuffrè GM; Quaranta D; Costantini EM; Citro S; Martellacci N; De Ninno G; Vita MG; Guglielmi V; Rossini PM; Calabresi P; Marra C
    Neurobiol Dis; 2023 Oct; 186():106267. PubMed ID: 37652185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum neurofilament light chain in behavioral variant frontotemporal dementia.
    Steinacker P; Anderl-Straub S; Diehl-Schmid J; Semler E; Uttner I; von Arnim CAF; Barthel H; Danek A; Fassbender K; Fliessbach K; Foerstl H; Grimmer T; Huppertz HJ; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer B; Lauer M; Maler JM; Mayer B; Oeckl P; Prudlo J; Schneider A; Volk AE; Wiltfang J; Schroeter ML; Ludolph AC; Otto M;
    Neurology; 2018 Oct; 91(15):e1390-e1401. PubMed ID: 30209235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis.
    Gaur A; Rivet L; Mah E; Bawa KK; Gallagher D; Herrmann N; Lanctôt KL
    Ageing Res Rev; 2023 Nov; 91():102046. PubMed ID: 37647995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Application of Plasma Neurofilament Light Chain in a Memory Clinic: A Pilot Study.
    Shim Y
    Dement Neurocogn Disord; 2022 Apr; 21(2):59-70. PubMed ID: 35585907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions.
    Abed SS; Hamdan FB; Hussein MM; Al-Mayah QS
    J Med Life; 2023 Feb; 16(2):284-289. PubMed ID: 36937471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma neurofilament light chain associated with impaired regional cerebral blood flow in healthy individuals.
    Nabizadeh F; Ward RT; Balabandian M; Kankam SB; Pourhamzeh M
    Curr J Neurol; 2023 Oct; 22(4):221-230. PubMed ID: 38425361
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.